中华医学杂志（英文版）2023，Vol.136Issue(24)：3022-3024,3.DOI:10.1097/CM9.0000000000002689
Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer
Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer
Da Qian 1Tao Zhou 2Hanchu Xiong 3Yuhao Xu 4Jie Qiu 4Yihao Wu 5Weimin Hong 2Xuli Meng6
作者信息
- 1. Department of Burn and Plastic Surgery-Hand Surgery,The Changshu Hospital Affiliated to Soochow University,Changshu,Jiangsu 215000,China
- 2. Faculty of Basic Medicine,Hangzhou Medical College,Hangzhou,Zhejiang 310014,China
- 3. Cancer Center,Department of Radiation Oncology,Zhejiang Provincial People's Hospital,Affiliated People's Hospital,Hangzhou Medical College,Hangzhou,Zhejiang 314408,China
- 4. Second Clinical College,Zhejiang Chinese Medical University,Hangzhou,Zhejiang 310014,China
- 5. College of Pharmaceutical Science,Zhejiang University of Technology,Hangzhou,Zhejiang 310014,China
- 6. Cancer Center,Department of Breast Surgery,Zhejiang Provincial People's Hospital,People's Hospital of Hangzhou Medical College,Hangzhou,Zhejiang 314408,China
- 折叠
引用本文复制引用
Da Qian,Tao Zhou,Hanchu Xiong,Yuhao Xu,Jie Qiu,Yihao Wu,Weimin Hong,Xuli Meng..Hsa-miR-105-5p acts as an oncogene in triple-negative breast cancer[J].中华医学杂志（英文版）,2023,136(24):3022-3024,3.基金项目
This study was supported by grants from the Natural Science Foundation of China(No.82102814),Zhejiang Provincial Natural Science Foundation of China under grants(No.LQ22H160053),Zhejiang Provincial People's Hospital Scientific Research Foundation for The Excellent Youth(No.ZRY2020B007)and Suzhou Youth Science and Technology Program(No.KJXW2021067). （No.82102814）
